Purchase Order 36C25224P1314

Award Date 9/24/24
Potential Completion Date 10/24/24
Potential Value $99K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $49,748.73 firm fixed-price purchase order contract awarded by the Veterans Health Administration (VHA) of the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of tumor treating fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract supports the VA's efforts to expand veteran access to...
This is a $49,748.73 firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services for the treatment of glioblastoma and mesothelioma at VA medical facilities. The...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract does not utilize any set-aside designations. Novocure acts...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $21,000.00, is for the delivery of Novocure's Optune Plus Transducers, which are part of the company's Optune system for delivering Tumor Treating Fields (TTFields) therapy to treat solid tumor cancers, including glioblastoma and mesothelioma. This contract is not...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $99,497.46, is for the delivery of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The Optune system delivers alternating electric...
This is a Firm Fixed Price delivery order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $99,497.46, is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. Novocure's Optune system delivers alternating electric fields to disrupt solid...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Plus transducers, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract is a firm-fixed-price purchase order with a period of performance...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $49,748.73 firm-fixed-price delivery order contract to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical facilities nationwide. This delivery order is issued under Novocure's existing...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $16,582.91 firm fixed-price purchase order is for the delivery of Novocure's Optune transducer arrays, device rentals, and associated support services. Novocure's Optune system delivers alternating electric fields to disrupt solid tumor cancer cell division and is FDA-approved for the...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat glioblastoma, mesothelioma, and other solid tumor cancers. Novocure is the prime contractor and will deliver the Optune...

This $99,497.46 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the delivery of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical centers. Novocure's proprietary Optune system delivers alternating electric fields to disrupt solid tumor cancer cell division and is FDA-approved for the treatment of glioblastoma and mesothelioma. This award is part of a larger 5-year Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) with a $28.85 million ceiling, which enables the VA to efficiently procure Novocure's cancer treatment technologies. The contract does not utilize any set-aside designations. This purchase order supports the VA's mission of expanding veterans' access to cutting-edge cancer therapies.

Generated 9/26/24, 9:07 AM